These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 17260848)

  • 21. Shingles vaccine found effective; could offer relief to millions. Zoster vaccine could be available as early as next year to prevent this painful skin and nerve condition.
    Health News; 2005 Sep; 11(9):5-6. PubMed ID: 16208806
    [No Abstract]   [Full Text] [Related]  

  • 22. Varicella-zoster vaccine.
    Woo EJ; Ball R; Braun MM
    N Engl J Med; 2007 Jul; 357(1):88. PubMed ID: 17611214
    [No Abstract]   [Full Text] [Related]  

  • 23. Varicella vaccine in the United States: a decade of prevention and the way forward.
    Gershon AA; Arvin AM; Levin MJ; Seward JF; Schmid DS
    J Infect Dis; 2008 Mar; 197 Suppl 2():S39-40. PubMed ID: 18419405
    [No Abstract]   [Full Text] [Related]  

  • 24. [Herpes zoster and post-herpetic neuralgia in older adults].
    Lang PO; Zarate-Lagunes M; Pautex S
    Rev Med Suisse; 2008 Nov; 4(178):2398-402, 2404. PubMed ID: 19051627
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Herpes zoster vaccination among adults aged 60 years or older in the United States, 2007: uptake of the first new vaccine to target seniors.
    Lu PJ; Euler GL; Jumaan AO; Harpaz R
    Vaccine; 2009 Feb; 27(6):882-7. PubMed ID: 19071175
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Shingrix--an adjuvanted, recombinant herpes zoster vaccine.
    Med Lett Drugs Ther; 2017 Dec; 59(1535):195-196. PubMed ID: 29186082
    [No Abstract]   [Full Text] [Related]  

  • 27. National survey of primary care physicians regarding herpes zoster and the herpes zoster vaccine.
    Hurley LP; Harpaz R; Daley MF; Crane LA; Beaty BL; Barrow J; Babbel C; Marin M; Steiner JF; Davidson A; Dickinson LM; Kempe A
    J Infect Dis; 2008 Mar; 197 Suppl 2():S216-23. PubMed ID: 18419400
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlates of Protection for Herpes Zoster Vaccine: Evaluating Candidate Immunological Variables.
    Dunning AJ
    J Infect Dis; 2015 Nov; 212(9):1521. PubMed ID: 25985903
    [No Abstract]   [Full Text] [Related]  

  • 29. Herpes zoster vaccine: clinical trial evidence and implications for medical practice.
    Burke MS
    J Am Osteopath Assoc; 2007 Mar; 107(3 Suppl 1):S14-8. PubMed ID: 17488883
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recombinant herpes zoster vaccine after heart transplantation: A single-center experience.
    Barghash MH; Taimur S; Rana M; Behar J; Mancini DM
    J Heart Lung Transplant; 2020 Dec; 39(12):1501-1503. PubMed ID: 33067105
    [No Abstract]   [Full Text] [Related]  

  • 31. The shingles vaccine. Question: if you've had shingles, should you get the vaccine to protect yourself from getting it again?
    Harv Health Lett; 2011 Mar; 36(5):6. PubMed ID: 21649970
    [No Abstract]   [Full Text] [Related]  

  • 32. Varicella virus and the herpes zoster vaccine. A review of Zostavax and the new AFIP recommendations.
    Ebede TL; Zippin JH
    J Drugs Dermatol; 2008 Dec; 7(12):1173-6. PubMed ID: 19137773
    [No Abstract]   [Full Text] [Related]  

  • 33. Herpes zoster vaccination: benefits and barriers.
    Komara FA
    J Am Osteopath Assoc; 2009 Jun; 109(6 Suppl 2):S22-4. PubMed ID: 19553633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessing correlates of protection in vaccine trials.
    Wittes J
    J Infect Dis; 2014 Nov; 210(10):1523-5. PubMed ID: 24823622
    [No Abstract]   [Full Text] [Related]  

  • 35. Reducing the incidence and severity of herpes zoster and PHN with zoster vaccination.
    Gelb LD
    J Am Osteopath Assoc; 2009 Jun; 109(6 Suppl 2):S18-21. PubMed ID: 19553631
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Perspective on live varicella vaccine.
    Gershon AA; Katz SL
    J Infect Dis; 2008 Mar; 197 Suppl 2():S242-5. PubMed ID: 18419404
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of the varicella vaccination program on herpes zoster epidemiology in the United States: a review.
    Reynolds MA; Chaves SS; Harpaz R; Lopez AS; Seward JF
    J Infect Dis; 2008 Mar; 197 Suppl 2():S224-7. PubMed ID: 18419401
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Varicella-zoster vaccine.
    Lang PO; Herrmann F; Michel JP
    N Engl J Med; 2007 Jul; 357(1):89. PubMed ID: 17615638
    [No Abstract]   [Full Text] [Related]  

  • 39. Incidence and clinical characteristics of herpes zoster after lung transplantation.
    Manuel O; Kumar D; Singer LG; Cobos I; Humar A
    J Heart Lung Transplant; 2008 Jan; 27(1):11-6. PubMed ID: 18187081
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Herpes zoster vaccine (Zostavax) revisited.
    Med Lett Drugs Ther; 2010 May; 52(1339):41. PubMed ID: 20508580
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.